In the past one year, the Nifty Pharma Index has shed 12.4% as against the 1% gains in the benchmark Nifty 50. Mutual Funds that bet on pharma stocks have fallen 14.2% on an average in the past one year. So far in 2022, they have declined 12.4% on an average, according to Value Research.
Singtel likely to sell stake worth Rs 8,500 crore in Bharti Airtel via block deal: Report
Singtel plans to offload nearly 5 crore Bharti Airtel shares via block deals worth ₹8,500 crore at a 3.6% discount. Bharti Airtel recently reported a
May 15, 2025